Eric H. Schoenstein
Jensen Investment Management
Jensen Investment Management Portfolio 13F
Eric H. Schoenstein Holdings Activity
- Portfolio value:
- $12.68B≈ (-$104M≈)
- Previous value:
- $12.79B≈
- # of changes:
- 63
- New positions:
- 1
- Reported for:
- 31 Mar 2023 (Q1)
- Latest filing date:
- 08 May 2023
Jensen Investment Management has disclosed a total of 63 changes to the portfolio in the (2023 Q1) SEC report(s): increased the number of shares of 14, bought 1 totally new, decreased the number of shares of 44 and completely sold out 4 position(s).
What stocks did Eric H. Schoenstein buy in 2023 Q1?
During 2023 Q1 Eric H. Schoenstein has bought 15 securities out of which top 5 purchases (by % change to portfolio) were (ACN) Accenture plc (added shares +6.28%), (SBUX) Starbucks Corp (added shares +4.12%), (MRSH) Marsh & McLennan Companies, Inc (added shares +10.67%), (INTU) Intuit Inc (added shares +7.39%) and (PFE) Pfizer Inc (added shares +10.37%).
In the 2023 Q1 report(s) the following changes have been made to the top investments: (MSFT) Microsoft Corp (reduced shares -3.34%), (PEP) PepsiCo Inc (reduced shares -3.71%), (SYK) Stryker Corp (reduced shares -3.34%), (ACN) Accenture plc (added shares +6.28%) and (AAPL) Apple Inc (reduced shares -3.51%).
63 results
| History | Ticker | Name |
% or activity |
Shares change |
Shares held after* |
% change to portfolio |
Reported price* |
% difference current price* |
% of portfolio |
Held since* | Held for* |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
Bio-Techne Corp
|
new
|
+37,270
|
37,270
|
+0.02%
|
$72.43
|
-0.42%($72.12)
|
0.02%
|
2023 Q1
|
≈ 0.25 years
|
|
|
|
Kellanova
|
+31.72%
|
+20,540
|
85,300
|
+0.01%
|
$66.66
|
|
0.04%
|
2019 Q4
|
≈ 3.50 years
|
|
|
|
Lennox International Inc
|
+27.48%
|
+4,630
|
21,480
|
+0.01%
|
$245.32
|
+82.16%($446.88)
|
0.04%
|
2018 Q3
|
≈ 4.75 years
|
|
|
|
Kroger Company
|
+13.21%
|
+17,180
|
147,260
|
+0.01%
|
$49.06
|
+17.92%($57.85)
|
0.06%
|
2016 Q3
|
≈ 6.75 years
|
|
|
|
Aon PLC
|
+12.64%
|
+460
|
4,100
|
+0%
|
$313.00
|
+13.29%($354.58)
|
0.01%
|
2022 Q4
|
≈ 0.50 years
|
|
|
|
ResMed Inc
|
+12.48%
|
+2,180
|
19,650
|
+0%
|
$215.95
|
+2.26%($220.84)
|
0.03%
|
2021 Q4
|
≈ 1.50 years
|
|
|
|
Charles River Laboratories
|
+11.70%
|
+2,700
|
25,780
|
+0%
|
$198.03
|
+19.22%($236.10)
|
0.04%
|
2022 Q2
|
≈ 1.00 year
|
|
|
|
Marsh & McLennan Companies, Inc
|
+10.67%
|
+279,134
|
2,894,598
|
+0.36%
|
$164.88
|
+15.21%($189.96)
|
3.76%
|
2021 Q2
|
≈ 2.00 years
|
|
|
|
Pfizer Inc
|
+10.37%
|
+1,091,421
|
11,617,395
|
+0.35%
|
$40.38
|
-36.89%($25.48)
|
3.70%
|
2018 Q2
|
≈ 5.00 years
|
|
|
|
Intuit Inc
|
+7.39%
|
+74,522
|
1,083,014
|
+0.26%
|
$440.09
|
-27.24%($320.21)
|
3.76%
|
2017 Q3
|
≈ 5.75 years
|
|
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
* Current price: this can be a delayed price and may not reflect the real-time market value, however it is too close.
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* Held since / Held for: calculated since the latest "new buy" position. If the security was previously exited and re-entered, only the most recent holding period is counted.